Connecticut Innovations

[Connecticut Innovations](http://www.ctinnovations.com) provides strategic capital and operational insight to to companies in high-tech industries such as energy, biotechnology, information technology, and photonics. Their mission is to be the leading source of financing and ongoing support for Connecticut’s innovative, growing companies. By offering flexible financing, strategic guidance and introductions to valuable partners, Connecticut innovations enable promising businesses to thrive.

David M. Audibert

MD of Investments

Matthew A. Bloom

Director, Investments

Lauren Carmody

Vice President of Marketing & Communications

Margaret Cartiera

VP and Fund Manager

Joseph J. Casparino

MD of Information Technology

Jeremy Crisp

EVP and Chief Innovation Officer

Tamyra Davis

Senior Associate

Cyndi Green

Managing Director

Robert A. Kennedy

Director

Barbara Lesh

Program Associate of Small Business Innovations

Matthew J. McCooe

CEO

Ted Murphy

Senior Vice President, Venture Lending

Patrick O'Neill

Managing Director

Matt Panicali

Associate, Investments

Antonio Roberto

Managing Director, Strategic Investments

Philip Siuta

COO and CFO

Matthew D. Storeygard

Managing Director, Investments

Daniel Wagner

Senior Managing Director, Investments

Linda Wieleba

SVP and Senior Loan Officer

Wenping Zhou

Bioscience Investment Associate

285 past transactions

Inbox Health

Series B in 2023
Inbox Health's mission is to greatly reduce the administrative waste in healthcare, by streamlining the patient billing and payment experience. Their product is a patient billing and communication platform that uses patient data to tailor a billing process specific to the patient’s situation and behavior patterns.

Noteworthy AI

Seed Round in 2022
Climate change creates new risks for electric utilities. From more frequent and intense storms to droughts that create wildfire-friendly conditions, it’s now more critical than ever for these companies to enact mitigation measures that account for these risks. One mitigation is the proactive inspection and inventory of grid assets at-scale, usually by piloting aerial drone missions to collect imagery and video on each asset. While these methods have proven to increase both grid safety and resiliency, most are employed on the transmission grid but not on the distribution grid. This is because, compared to transmission grid assets, distribution grid assets are too numerous, too geographically dispersed, are often located in densely populated areas, and the aerial view is often obscured by vegetation for much of the year. This makes piloting drone inspection missions over distribution grid assets extremely difficult. Yet, 90% of power outages occur on the distribution grid and there are cases of faulty distribution grid equipment sparking wildfires, such as the recent Silverado Fire in Southern California. Noteworthy AI solves this problem by ensuring that distribution grid assets are adequately inspected and monitored. Our solution combines hardware at the Edge and software in the Cloud to help electric utilities inspect and inventory distribution grid assets at scale. Our Edge hardware mounts directly on electric utility fleet vehicles (e.g. repair trucks) and uses proprietary computer vision to inspect and inventory distribution poles and their components with no impact on crew duties. Results are sent to our Cloud software in real-time. This converts non-productive fleet vehicle travel time into active inspection and monitoring at a low cost, enabling electric utilities to reap grid resiliency and safety benefits on the distribution grid as well.

FinTron

Series A in 2022
FinTron Invest LLC, founded in 2018 and based in Fairfield, Connecticut, provides investment tools aimed at new investors. The company offers a digital broker-dealer and banking application that allows users to evaluate risk, search for stocks by sector, and construct investment portfolios. In addition to its investment services, FinTron focuses on promoting financial education, offering affordable financial products, and supporting philanthropic initiatives. The company's platform consolidates essential financial data, enabling users to track their debt, savings, and investment accounts in one place while receiving updates on their financial activities. FinTron is committed to enhancing financial freedom and security for its users.

Torigen Pharmaceuticals

Venture Round in 2022
Torigen Pharmaceuticals is a company focused on being at the forefront of immuno-oncology innovation. They strive to bring novel approaches to the market to tackle companion animal cancers, building on years of existing scientific research and pushing the boundaries of innovation.

Plazmod

Pre Seed Round in 2022
Plasma based green manufacturing of batteries and energy materials for global electrification

Upswing Health

Seed Round in 2022
UpSwing Health is a developer of a community-powered digital sports medicine platform intended to transform healthcare for athletes. The company's platform offers athletes to identify injuries related to ankle, knee, elbow, and shoulder injuries, sprain, and fractures with use of digital technologies and AI, enabling athletes to find the path to recovery with convenience and equal access to quality information.

Encapsulate

Convertible Note in 2022
Producing an effective chemotherapy solution with a fully automated tumor-on-a-chip, pre-prescription analysis.

CoreChain Technologies

Seed Round in 2022
CoreChain Technologies is a business-to-business payments network built on blockchain technology.

Source Defense

Series B in 2022
In an industry focused on detection, Source Defense provides websites with the first ever prevention technology for attacks of third-party origin. We are the first ever SAAS platform that allows a site owner to set and enforce permissions, receive real-time alerts and monitor third-party vendors' behavior on their site. By removing the security considerations from third-party integrations, we can save countless man-hours spent on tests and integrations, allowing sites to focus on generating revenues and new opportunities while keeping the site visitors safe and the site in high performance.
Covr Financial Technologies, Inc. is a digitally enabled brokerage general agency that specializes in providing life, long-term care, and disability insurance solutions for financial institutions and their clients. Founded in 2016 and based in Boise, Idaho, Covr offers a range of digital platforms, including Covr Advisor for financial advisors, Covr Consumer for banks and credit unions to sell insurance online, and Covr Insights for managing in-force life insurance policies. The company serves over 24,000 financial advisors and approximately 13 million customers across 30 financial institutions, such as wealth management firms and credit unions. Covr's technology empowers financial professionals to address their clients' insurance needs effectively while facilitating direct access to products for consumers. The company has garnered the support of prominent venture capital firms and boasts an advisory board composed of notable leaders from the financial services sector.

1906

Venture Round in 2022
1906 is a pioneering brand in the cannabis edibles sector, focusing on innovative functional formulations that combine cannabis with ethnobotanicals. The company offers a diverse range of products designed to deliver specific experiences, such as promoting sleep, energy, arousal, relaxation, cognitive focus, and an uplifting mood. Utilizing single-strain organic cannabis, 1906 ensures that its offerings are both consistent and fast-acting. In addition to providing health-oriented nutritional supplements, the company is committed to supporting medicinal cannabis research by investing a portion of its revenue in clinical trials and education for healthcare practitioners. Furthermore, 1906 emphasizes corporate social responsibility by creating employment opportunities for individuals previously incarcerated due to cannabis-related offenses, addressing the social impacts of a century of prohibition.

Nest Collaborative

Seed Round in 2022
Nest Collaborative is a provider of on-demand lactation counseling services intended to offer a collection of international board certified lactation consultants who conduct online, video appointments to help guide moms through the breastfeeding process. The company's services are offered via an online platform that offers reimbursed maternal, neonatal and lactation counseling services, enabling women to avail safe, convenient and affordable access to quality pediatric care, at home.

NourishedRx

Seed Round in 2022
NourishedRx is a provider of personalized food solutions for a health plan and providers' most vulnerable members such as those facing diet-sensitive chronic health conditions and who are often at risk of nutrition insecurity. The company also offers education and encouragement to individuals to create lasting behavior change. Their custom solutions deliver increased member engagement and satisfaction, improved clinical outcomes, and meaningful cost savings. It was founded in 2019 in Stamford, Connecticut.

Wellinks

Series C in 2021
Wellinks is a medical technology company that specializes in the design and development of medical devices aimed at improving respiratory health. Founded in 2014 and headquartered in Fairfield, Connecticut, the company offers innovative solutions, including Flyp, a handheld nebulizer specifically designed for patients with respiratory diseases. Wellinks operates within the health and wellness sector, focusing on enhancing the quality of care for individuals suffering from such conditions.

VeraDermics

Series A in 2021
VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions such as warts. It offers a dissolvable microneedle patch solution that administers immunotherapy without any pain, a treatment that stimulates the body’s own immune system to fight off the wart virus. The patch is applied like a Band-Aid and remains on the skin for less than an hour. During that time, the microneedles, which are composed of the immune-stimulators in a sustained-release polymer matrix, dissolve from the adhesive backing and are implanted into the skin. The adhesive can then be removed leaving the microneedles to dissolve in the skin over weeks. During that time, immune stimulators are steadily released directly into the wart. The San Antonio, Texas-located company was founded in 2019 by Lauren Durso, Reid Waldman, Ming Lee, Madeline DeWane, and Kyle Ryder.

futuresTHRIVE

Seed Round in 2021
FuturesTHRIVE develops an AI platform to identify and track pediatric mental health easily. FuturesTHRIVE's platform uses a combination of artificial intelligence, sentiment analysis, and machine learning to provide a mental health baseline that can be used by doctors and families to better understand a child's mental health qualities, thereby helping to identify mental health conditions in children easily and early.

Owl's Brew

Series A in 2021
Brew Lab Tea creates all-natural loose leaf tea blends, carefully crafted in NYC. Founded in 2013, by tea sommelier Jennie Ripps and Maria Littlefield, Owl's Brew sells two product lines. Owl's Brew Mixer, tea-based craft cocktail mixers, and Owl's Brew Boozy Tea.

DiA Imaging Analysis

Venture Round in 2021
DiA Imaging Analysis Ltd. specializes in developing advanced decision support systems for the automatic diagnosis of cardiac function through echocardiographic examinations. The company offers a suite of AI-powered applications, including LVivo EF for ejection fraction analysis, LVivo RV for right ventricle assessment, and LVivo Strain for evaluating myocardial contraction and strain, which serve as early indicators of reduced left ventricular function. Additional tools include LVivo SWM for segmental wall motion evaluation, LVivo Seamless for optimal view selection, and LVivo SAX, which aids in detecting coronary heart disease. DiA also provides mobile ultrasound solutions with LVivo Mobile and converts traditional ultrasound to bladder scanning with LVivo Bladder. Founded in 2009 and based in Beersheba, Israel, DiA holds FDA and CE clearances for its cardiac tools, making its automated solutions accessible for integration into ultrasound devices and healthcare IT systems, addressing challenges in image acquisition and analysis faced by clinicians worldwide.

Shelf

Series B in 2021
The workplace has changed. Teams now live in different parts of the country and, possibly, even the world. Collaborating across projects and continents is becoming the new norm. Distributed teams live and die by their ability to quickly learn, share key knowledge and take the right action at the right time. But there is a problem. Currently stuff is scattered and disorganized all over the place and the products meant to solve this content sprawl, like SharePoint and Confluence, are expensive, difficult to use and hard to search. In building a solution the Shelf team went beyond software and set out to understand the Science of Organization. They consulted Harvard librarians, change management experts, and information architects. With the help of these global thought leaders, knowledge management best practices were built into the core of the product. Shelf is designed to help declutter and organize your most important content. Everything about Shelf, from our search to our customer support, reflects the passion and drive of our team to build a better way to harness knowledge and make things easy to find and share. People use Shelf to find the information they need to publish a story, make a pitch, or close an important deal, without the pain of redoing work or wasting time tracking things down. Its Shelf’s mission to help millions of distributed teams throughout the globe accelerate their ability to learn, share and succeed. We are reimagining the library for the workplace of tomorrow and won’t stop until we’ve integrated all the important places where important content is buried. Shelf is the missing link in a rapidly evolving, distributed workplace.

CoreChain Technologies

Pre Seed Round in 2021
CoreChain Technologies is a business-to-business payments network built on blockchain technology.

CoreChain Technologies

Pre Seed Round in 2021
CoreChain Technologies is a business-to-business payments network built on blockchain technology.

BEKHealth

Seed Round in 2021
Developer of clinical research software designed to accelerate timelines by automating multiple impact processes. The company's software provides complete rapid trial feasibility, electronic medical record data processing, feasibility and site selection, precision patient trial matching and care coordination, enabling clients to reduce cost increase enrollment and streamline the clinical research process.

Triax Technologies

Series A in 2021
At Triax Technologies it is our mission to transform the most challenging work environments and industries through intelligent, innovative technology and real-time data collection and analytics to make worksites run safer, faster and smarter. To achieve this, we deliver a fully connected Internet of Things (IoT) platform through a proprietary communication hub designed for Construction, Oil & Gas, Energy, Heavy Industrial and other challenging IT environments. Our flagship Spot-r system elevates worksite visibility, safety, security and risk, connecting workers, equipment and operations through a scalable, minimal infrastructure network, wearable and sensor devices, and a cloud-based dashboard. By providing real-time, data-driven visibility into site access, worker and equipment location, manpower, safety incidents, and evacuation and muster procedures, Spot-r enables actionable insights, helping firms streamline processes and work safer and smarter. In April 2020, we launched Proximity Trace, an IoT solution that provides proximity distancing alerts and contact tracing for the workplace. The solution offers added protection for essential workers during the COVID-19 pandemic and helps companies get workers back to work safely, while addressing recommended social distancing practices. More information can be found at: https://www.triaxtec.com/

Lumeda

Series A in 2021
Lumeda Inc. develops photonic tools that enable practical intraoperative photodynamic therapy (PDT) for treating lung cancer. It offers light delivery photonics instrumentation and a software to automate PDT light delivery to targeted tumor and light dosimetry profiles. The company’s solution also enables intraoperative PDT procedure to conventional non-small cell lung cancer tumor resection to address tumor margin and reduce post-operative recurrence. Lumeda Inc. was founded in 2020 and is based in Rocky Hill, Connecticut.

Inbox Health

Series A in 2021
Inbox Health's mission is to greatly reduce the administrative waste in healthcare, by streamlining the patient billing and payment experience. Their product is a patient billing and communication platform that uses patient data to tailor a billing process specific to the patient’s situation and behavior patterns.

Enko Chem

Venture Round in 2021
Enko Chem discovers and develops novel products for farmers to protect their crops from pests and diseases. Their proprietary technology platform represents a revolutionary approach to rapidly discover safe and economical solutions that are needed to ensure sustainable food production. It was founded in 2017 and headquartered in Woburn, Massachusetts.

Artizan Biosciences

Series A in 2021
Artizan Biosciences develops small molecule drugs targeting human diseases, utilizing its IgA-SEQ technology platform to identify disease-driving bacteria within the intestinal microbiota. Founded in 2016 and headquartered in New Haven, Connecticut, the company focuses on creating new and potentially curative treatments. With a commitment to advancing pharmaceutical drug development, Artizan Biosciences aims to address unmet medical needs through innovative approaches in biotechnology.

TrialJectory

Series A in 2021
Trialjectory Inc. develops an AI-based clinical trial-matching platform. The company’s platform uses self-reported clinical information to facilitate clinical trial search, matching and enrollment by cancer patients and their physicians. It connects pharmaceutical companies and physicians to patients with treatment options. The company was founded in 2017 and is based in New York, New York.

Nest Collaborative

Seed Round in 2021
Nest Collaborative is a provider of on-demand lactation counseling services intended to offer a collection of international board certified lactation consultants who conduct online, video appointments to help guide moms through the breastfeeding process. The company's services are offered via an online platform that offers reimbursed maternal, neonatal and lactation counseling services, enabling women to avail safe, convenient and affordable access to quality pediatric care, at home.

Diameter Health

Series B in 2020
Diameter Health, Inc. develops innovative software solutions aimed at enhancing data interoperability for healthcare organizations. The company's flagship product, Fusion, facilitates intelligent data exchange by normalizing and cleansing information from certified electronic health records (EHRs), thereby transforming it into clinically relevant data for point-of-care use and analytics. In addition to Fusion, Diameter Health offers various tools, including Data Dashboard, which provides instant data quality ratings and metrics for clinical document accuracy; Quality, which supports certified quality reporting of e-measures; and Payer Edition, designed for generating standard supplemental reporting data. Other offerings include Subscribe, which allows for automatic updates for specific patient populations, and a scalable Hosted Solution. Diameter Health serves a diverse clientele, including government agencies, health information exchanges, payers, healthcare IT vendors, life insurers, and health systems. Founded in 2013, the company operates from its offices in Farmington, Connecticut, and Wellesley, Massachusetts.

Athena Therapeutics

Seed Round in 2020
Athena Therapeutics, LLC develops drugs that targets NAD metabolism defects in cancer. It matches the drugs with cancer NAD metabolism profiles that allow selective tumor targeting over normal tissues. The company was incorporated in 2018 and is based in New Haven, Connecticut.

Alphina Therapeutics

Venture Round in 2020
Alphina Therapeutics is a biotechnology company that aims to leverage proprietary biomarkers and breakthrough insights for cancer patients. Its focus is on leveraging the synthetic lethal context of certain cancer patient subsets that have NAD Metabolic Deficiencies (NMD) through the development of companion diagnostics. Their goal is to develop best-in-class targeted therapies against the NAD pathway nodes in patients whose cancers exhibit hallmarks of NMD and rapidly translate these into the clinic.

WRM Software

Seed Round in 2020
WRM Software develops business productivity applications aimed at enhancing operational efficiency and improving business processes. The company's offerings include specialized tools such as the storm manager and ops manager applications, which facilitate seamless connectivity between field and office operations. These applications are designed to be user-friendly, ensuring that all team members have access to the latest information at any time. WRM Software's solutions support emergency response operations and field service management, helping organizations streamline their management processes.

Azitra

Series B in 2020
Azitra Inc. is a clinical-stage medical dermatology company based in Farmington, Connecticut, that focuses on developing microbiome-based therapeutics for skin diseases. Established in 2014, the company utilizes extensive scientific knowledge of the skin microbiome to create innovative treatments for various adverse skin conditions. Its technology platform is built around a proprietary strain of the natural commensal bacteria Staphylococcus epidermidis, developed in collaboration with researchers from Yale University and the Jackson Laboratory. Azitra aims to address unmet medical needs in dermatology through its novel product offerings.

Point Pickup

Series A in 2020
Point Pickup Technologies (PPUP) is a mobile APP delivery platform solving on-demand, pre-scheduled, and recurring same-day delivery needs. PPUP is a multi-modal single platform for all same-day delivery solutions (middle and last-mile) it services the widest range of industries and company sizes, with an emphasis on big-box retail, grocery, liquor/specialty, industrial, pharmaceutical, and manufacturing businesses. Based on its precision matching technology platform and diverse network of independent drivers including everyday people with cars and professional commercial vehicle drivers, PPUP’s complete delivery model solves the unique challenges of the same-day delivery market. PPUP services all major markets throughout the United States while also uniquely focusing on the under-served secondary markets.

Biorez

Seed Round in 2020
Biorez, Inc. is a medical device company focused on developing bioresorbable scaffold implants designed to regenerate functional tissue in vivo. The company’s lead product is an off-the-shelf implant for anterior cruciate ligament (ACL) reconstruction, which eliminates the need for harvesting donor tissue and offers a superior alternative to cadaver-based materials. Biorez utilizes patented technology involving a degradable polymer for its orthopedic implants, including the L-C Ligament and biorez GRAFT, an FDA-cleared device for soft tissue augmentation of the rotator cuff. Founded in 2008 and based in New Haven, Connecticut, Biorez aims to commercialize its ACL technology while expanding its platform for innovative clinical solutions.

IvyTech Design LLC

Seed Round in 2020
Our patent-pending technology would give the surgeon better access to joint and fracture surfaces during distraction as well as more accurate alignment during compression, which could reduce the risk of complications due to improper bone fusion. Our devices were tailored for specific orthopedic applications, including correction of diaphyseal nonunion in long bones, reduction of transverse fractures in foot and hand, and anterior cervical discectomy and fusion in the spine.

Shelf

Series A in 2020
The workplace has changed. Teams now live in different parts of the country and, possibly, even the world. Collaborating across projects and continents is becoming the new norm. Distributed teams live and die by their ability to quickly learn, share key knowledge and take the right action at the right time. But there is a problem. Currently stuff is scattered and disorganized all over the place and the products meant to solve this content sprawl, like SharePoint and Confluence, are expensive, difficult to use and hard to search. In building a solution the Shelf team went beyond software and set out to understand the Science of Organization. They consulted Harvard librarians, change management experts, and information architects. With the help of these global thought leaders, knowledge management best practices were built into the core of the product. Shelf is designed to help declutter and organize your most important content. Everything about Shelf, from our search to our customer support, reflects the passion and drive of our team to build a better way to harness knowledge and make things easy to find and share. People use Shelf to find the information they need to publish a story, make a pitch, or close an important deal, without the pain of redoing work or wasting time tracking things down. Its Shelf’s mission to help millions of distributed teams throughout the globe accelerate their ability to learn, share and succeed. We are reimagining the library for the workplace of tomorrow and won’t stop until we’ve integrated all the important places where important content is buried. Shelf is the missing link in a rapidly evolving, distributed workplace.

Encapsulate

Pre Seed Round in 2020
Producing an effective chemotherapy solution with a fully automated tumor-on-a-chip, pre-prescription analysis.

EyeControl

Series A in 2020
EyeFree Assistive Communication has developed EyeControl, an assistive communication device designed for ALS and other "locked-in" patients, including patients admitted into ICU departments which may be temporarily "locked-in" due to medical procedures or being connected to devices which don't enable communication. EyeControl is wearable, enabling 24/7 communication; affordable, so that any patient will have access to the device and simple to use, requiring dramatically lower training time than existing devices (as proven in a clinical trial). The device enables communication ranging from a call for help to a full conversation and it can be connected to other devices via Bluetooth. The user has the option to transmit a different language to the output speaker, allowing communication with a caregiver that may speak a different language.

Voiceitt

Series A in 2020
voiceitt Ltd designs and develops mobile applications which enable people with speech impairments to communicate and translates distorted pronunciation to intelligible speech. The company was founded in 2012 and is based in Ramat Gan, Israel.

GeneDx

Series C in 2020
Sema4 is a patient-centered predictive health company dedicated to advancing the diagnosis, treatment, and prevention of disease. With their innovative Sema4 Health Intelligence Platform, they’re using advanced network analysis to build better models of human health and deliver personalized insights for patients.

Enrich Therapeutics

Seed Round in 2020
Enrich Therapeutics Inc. develops a single cell isolation technology for global life science research. It offers LASUM, a LCD aided selection under microscope single cell isolation technology to work on suspension cells, adherent cells, and non-ideal tissue cell samples. Its life science tool improves scalability and affordability in applications, such as antibody drug discovery, NGS, and adoptive cell therapy development. The company also provides phage display library engineering/construction, affinity-on-demand binder selection, cell line development for CAR-T immunotherapy, B-cell isolation, adoptive cell therapy development, cell surface antibody discovery, and precision cell isolation for NGS analysis. The company was founded in 2018 and is based in Worcester, Massachusetts.

Simcha Therapeutics

Series A in 2020
Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer. The company uses directed evolution to engineer novel cytokines designed to unlock the precision and power of the immune system. Simcha’s lead program, ST-067, is a designer IL-18 cytokine that has shown potent antitumor effects in animal models, both as a monotherapy and when combined with anti-PD-1 checkpoint inhibitors, as described in Nature in June 2020. It was founded in 2018 and is headquartered in New Haven, Connecticut, USA.

Invixium

Series C in 2020
Headquartered in Toronto, Canada with an R&D centre in Ahmedabad, India, we believe that smart technology also has to be elegant. In simple terms, our products replace antiquated and vulnerable methods of entry such as keys, passwords, PINs and cards with modern and internet ready fingerprint based biometric products. Whether it is product packaging, the product itself or the user interface; every little aspect is exquisitely designed and consumer centric with a promise of touching your soul.

1touch.io

Series A in 2020
By continuously analyzing traffic and repository stores connected to your network, our network-based solution can detect all elements on the network that are storing, processing, and sharing personal data, both internally and externally. Whether structured or unstructured data, data in motion or at rest, and even data that is unknown to you, 1touch.io can track it for you.

Covr Financial Technologies

Convertible Note in 2020
Covr Financial Technologies, Inc. is a digitally enabled brokerage general agency that specializes in providing life, long-term care, and disability insurance solutions for financial institutions and their clients. Founded in 2016 and based in Boise, Idaho, Covr offers a range of digital platforms, including Covr Advisor for financial advisors, Covr Consumer for banks and credit unions to sell insurance online, and Covr Insights for managing in-force life insurance policies. The company serves over 24,000 financial advisors and approximately 13 million customers across 30 financial institutions, such as wealth management firms and credit unions. Covr's technology empowers financial professionals to address their clients' insurance needs effectively while facilitating direct access to products for consumers. The company has garnered the support of prominent venture capital firms and boasts an advisory board composed of notable leaders from the financial services sector.

IntelliBoard

Series A in 2020
IntelliBoard, Inc. is a company that specializes in providing analytic and reporting services tailored for educational communities and institutions utilizing learning management systems (LMS). Founded in 2015 and based in Monroe, Connecticut, IntelliBoard focuses on enhancing the reporting capabilities of LMS platforms. The company helps users extract and visualize statistical data collected within the LMS, presenting it in an accessible format that includes printable charts, graphs, and analytics on a single dashboard. This service aims to improve data-driven decision-making in education by offering comprehensive insights into learning activities and outcomes.

CytoVeris

Venture Round in 2020
CytoVeris develops optical-based probes enabling surgical oncologists to identify and remove tumor tissue during cancer resection surgery. The probes help to improve the surgeon’s ability to ensure clean margins are attained. It also develops technology to detect molecular signatures that cancer cells create due to the way that they hijack the cellular metabolic processes and corrupt DNA and protein pathways which creates signature variations of molecules such as lipids, proteins, and metabolites that can be detected with their OncoMap system. It was formed by Alan Kersey in Farmington, Connecticut in 2018.

Spairo

Seed Round in 2020
MindNest Health, Inc. operates a digital parent training platform focused on enhancing children's development through evidence-based interventions. Founded in 2016 and based in New Haven, Connecticut, the company provides programs for conditions such as ADHD, autism, and disruptive behaviors, as well as developing resources for anxiety and substance abuse. The platform is designed to empower parents by equipping them with clinically validated techniques used by experts, thereby reducing barriers to accessing behavioral health support. By enabling parents to practice new skills effectively, MindNest Health aims to improve children's care while alleviating parental stress. The company's mission includes promoting a society where families can thrive and reducing overall care costs for employers and payers.

WAVE Drowning Detection Systems

Pre Seed Round in 2020
WAVE was created with a mission to end drowning, a leading cause of death in children and adults. Our product works with lifeguards and parents to detect drowning at the first sign of danger.

ReferWell

Venture Round in 2020
ReferWell connects providers into Virtually Integrated Networks that optimize transitions of care. We help you drive the patient journey through the last mile with complete visibility into all interactions—so providers and payers can close the loop efficiently. With our system, you’ll direct patients toward the highest-quality providers, increase patient compliance, reduce leakage and close more care gaps. Clients raise revenue by increasing keepage, improving STAR ratings and getting more members’ HCC coding updated. Our comprehensive suite of services connects to all your EMRs for streamlined referrals, point-of-care appointment scheduling and care team support, including provider directory management, eConsult and telehealth capabilities.

ProteoWise

Venture Round in 2020
ProteoWise’s technology provides a unique combination of high information content, high throughput, and low cost - all while simplifying the western blot dramatically. This combination is what’s driving the genomic revolution and is needed for proteomics. ProteoWise is founded by a seasoned team of scientists from the Strittmatter Lab at Yale University with a history of innovation.

Inbox Health

Venture Round in 2020
Inbox Health's mission is to greatly reduce the administrative waste in healthcare, by streamlining the patient billing and payment experience. Their product is a patient billing and communication platform that uses patient data to tailor a billing process specific to the patient’s situation and behavior patterns.

Aero Therapeutics

Pre Seed Round in 2020
Aero Therapeutics helps physicians in low-resource settings treat neonatal respiratory issues with sustainable, rugged and affordable medical devices.

Lessonbee

Pre Seed Round in 2020
Lessonbee Inc. is an online learning platform based in Mount Vernon, New York, that focuses on health and wellness education for students and professionals. Founded in 2017, the company offers a digital curriculum that includes adaptive lessons and a shared content library, allowing educators to access current materials, manage student assignments, and facilitate engaging reflective practices. Lessonbee provides culturally responsive and medically accurate health education tailored for students in grades K-12, promoting lifelong learning and healthy living. The platform aims to empower learners by transforming educational outcomes through accessible and meaningful content.

P2 Science

Series C in 2020
P2 Science, Inc. is a bio-renewable chemistry company based in Woodbridge, Connecticut, that specializes in the development and production of specialty chemicals derived from renewable feedstocks, such as vegetable oils. Founded in 2009 by a team that includes Yale scientists and industry experts, P2 Science focuses on creating high-value ingredients for various sectors, including flavors and fragrances, cosmetics, household and industrial cleaning, personal care, and agriculture. The company has developed innovative processes that allow for the production of vegetable-derived versions of fragrance ingredients traditionally sourced from petrochemicals. This shift towards renewable alternatives addresses the growing demand among major manufacturers to replace petrochemical ingredients with sustainable options. P2 Science operates a laboratory in New Haven, Connecticut, to advance its technology and collaborates with key partners throughout the supply chain to facilitate the commercialization of its products.

Enviro Power

Series A in 2020
Enviro Power, LLC, established in 2013 and based in Hartford, Connecticut, specializes in the development and marketing of innovative heating equipment for both residential and commercial use. The company's flagship products include the Commercial SmartWatt Boiler, which caters to light-commercial and high-end residential applications, and the Residential SmartWatt Boiler designed specifically for home usage. The SmartWatt Boiler technology platform aims to generate near-zero-cost electricity and offers backup power, potentially reducing utility bills for building owners while simultaneously lowering carbon footprints and enhancing grid resiliency.

IsoPlexis

Series C in 2020
IsoPlexis Corp is a life sciences company based in Branford, Connecticut, that specializes in developing a diagnostic platform designed to measure cellular immune responses in patients. Founded in 2013, the company's technology focuses on single-cell detection, allowing for the identification of diverse immune responses at the individual cell level. This platform plays a crucial role in assessing the safety and efficacy of therapeutics, as well as monitoring disease progression. By providing detailed insights into immune responses, IsoPlexis aims to enhance therapeutic development and inform clinical decision-making for healthcare professionals.

Biowave

Venture Round in 2020
BioWave Corporation manufactures and distributes pain blocking technology devices that block pain at the source. It offers BiowavePENS, a percutaneous electrical nerve stimulation device for treating severe chronic, acute, and post-operative musculoskeletal and neuropathic pain; BiowavePRO, a pain therapy system for treating common chronic, acute, and postoperative pain in any part of the body; BioWaveHOME, pain therapy system for treating common pain in any part of the body at home or while traveling; and BioWaveGO an over the counter pain relief technology. The company also provides accessories for its products and travel bags. It serves pro athletes, the U.S. veterans, active military, pain doctors, and other people. BioWave Corporation was incorporated in 1997 and is based in Norwalk, Connecticut.

Pineapple

Grant in 2019
Pineapple Tech Pty Ltd operates a platform that provides peer-to-peer insurance services. It offers short-term insurance coverage to its members. The company's platform allows users to pay and track their premiums online, while choosing the network they want to pool their premiums with. Pineapple Tech also operates a mobile application. The company was formerly known as Amyti Tech. Pineapple Tech Pty Ltd was founded in 2017 and is based in Johannesburg, South Africa.

TryCycle Data Systems

Pre Seed Round in 2019
The breakthrough insight that launched TryCycle, was discovered at a restaurant near Yale University in 2012. Here, two candidates for a Masters of Arts in Organizational Leadership reflected on the latest news in the State of Connecticut: people were dying from opioid abuse. Despite best efforts of well-intentioned people and agencies who provide treatment, therapy, medicine, and care, each operate in their respective industrial silos, and each provide incremental, situational support.

Azitra

Series A in 2019
Azitra Inc. is a clinical-stage medical dermatology company based in Farmington, Connecticut, that focuses on developing microbiome-based therapeutics for skin diseases. Established in 2014, the company utilizes extensive scientific knowledge of the skin microbiome to create innovative treatments for various adverse skin conditions. Its technology platform is built around a proprietary strain of the natural commensal bacteria Staphylococcus epidermidis, developed in collaboration with researchers from Yale University and the Jackson Laboratory. Azitra aims to address unmet medical needs in dermatology through its novel product offerings.

Paygilant

Private Equity Round in 2019
Paygilant Ltd. develops mobile fraud prevention solution for online transactions, payments, and money transfer frauds. It offers account takeover solutions, new account fraud solutions, and transactional fraud solutions. Paygilant Ltd. was founded in 2014 and is based in Ramat Gan, Israel.

Flyp Nebulizer

Series B in 2019
Flyp Nebulizer, the medical device is reinvented by Weblinks for respiratory care around the people who need it most. It works at ultrasonic speed to create a fine aerosol of medication. Flyp Nebulizer works quickly to deliver treatment within 7-minute average.

Wellinks

Series B in 2019
Wellinks is a medical technology company that specializes in the design and development of medical devices aimed at improving respiratory health. Founded in 2014 and headquartered in Fairfield, Connecticut, the company offers innovative solutions, including Flyp, a handheld nebulizer specifically designed for patients with respiratory diseases. Wellinks operates within the health and wellness sector, focusing on enhancing the quality of care for individuals suffering from such conditions.

GeneDx

Series B in 2019
Sema4 is a patient-centered predictive health company dedicated to advancing the diagnosis, treatment, and prevention of disease. With their innovative Sema4 Health Intelligence Platform, they’re using advanced network analysis to build better models of human health and deliver personalized insights for patients.

1touch.io

Convertible Note in 2019
By continuously analyzing traffic and repository stores connected to your network, our network-based solution can detect all elements on the network that are storing, processing, and sharing personal data, both internally and externally. Whether structured or unstructured data, data in motion or at rest, and even data that is unknown to you, 1touch.io can track it for you.

Budderfly

Venture Round in 2019
Budderfly is disrupting the energy industry by leading the digital transformation of energy consumption through its unique Energy-as-a-Service model. With no cost to its clients, Budderfly implements proprietary energy intelligence software, energy efficient technology upgrades that span more than 25 savings categories, and IoT devices that meter, control, and optimize energy usage at the point of consumption within each facility across the enterprise. Budderfly’s ongoing services and proactive maintenance ensure that a building’s energy infrastructure never becomes outdated. The result is significant, immediate and progressive energy expense savings, upgraded facilities, and a reduced carbon footprint for its client facilities.

Cytosolix

Convertible Note in 2019
Cytosolix is a biotechnology company focused on enhancing the efficacy of small molecule cancer therapeutics through innovative drug delivery systems. The company's primary offering is its Tumor Activated Permeability System, which develops novel oral and intravenous derivatives of established oncology drugs. These weakly-acidic derivatives are designed to improve the uptake of medications by cancer cells while minimizing absorption by healthy cells. This targeted approach aims to provide physicians with safer and more effective treatment options, particularly for drugs that may have dose-limiting toxicities. By addressing tumor acidity, Cytosolix seeks to improve patient outcomes in cancer therapy.

Cybrexa, Inc.

Series B in 2019
Cybrexa, Inc. develops DNA repair inhibitors for radio- and chemo-sensitizers in cancer therapeutics. The product consists of peptide-based technology that directly targets tumor microenvironment. Cybrexa, Inc. was formerly known as Cybrexa, Inc. The company was founded in 2016 and is based in New Haven, Connecticut.

Inbox Health

Seed Round in 2019
Inbox Health's mission is to greatly reduce the administrative waste in healthcare, by streamlining the patient billing and payment experience. Their product is a patient billing and communication platform that uses patient data to tailor a billing process specific to the patient’s situation and behavior patterns.

Tangen Biosciences

Series A in 2019
Tangen Biosciences LLC develops medical instrument that provides rapid nucleic acid detection, with the specificity and sensitivity of polymerase chain reaction (PCR) amplification.

Payveris

Series D in 2019
Payveris is the creator of The MoveMoney Platform, an Open API cloud-based platform that enables FIs to control, simplify + extend digital money movement capabilities to any application or device while lowering user experience friction, significantly reducing operating costs + future-proofing the IT investment. Shift from a product-centric digital payments model to a platform-centric model today!

Invixium

Series B in 2019
Headquartered in Toronto, Canada with an R&D centre in Ahmedabad, India, we believe that smart technology also has to be elegant. In simple terms, our products replace antiquated and vulnerable methods of entry such as keys, passwords, PINs and cards with modern and internet ready fingerprint based biometric products. Whether it is product packaging, the product itself or the user interface; every little aspect is exquisitely designed and consumer centric with a promise of touching your soul.

IsoPlexis

Series C in 2019
IsoPlexis Corp is a life sciences company based in Branford, Connecticut, that specializes in developing a diagnostic platform designed to measure cellular immune responses in patients. Founded in 2013, the company's technology focuses on single-cell detection, allowing for the identification of diverse immune responses at the individual cell level. This platform plays a crucial role in assessing the safety and efficacy of therapeutics, as well as monitoring disease progression. By providing detailed insights into immune responses, IsoPlexis aims to enhance therapeutic development and inform clinical decision-making for healthcare professionals.

Diameter Health

Series A in 2019
Diameter Health, Inc. develops innovative software solutions aimed at enhancing data interoperability for healthcare organizations. The company's flagship product, Fusion, facilitates intelligent data exchange by normalizing and cleansing information from certified electronic health records (EHRs), thereby transforming it into clinically relevant data for point-of-care use and analytics. In addition to Fusion, Diameter Health offers various tools, including Data Dashboard, which provides instant data quality ratings and metrics for clinical document accuracy; Quality, which supports certified quality reporting of e-measures; and Payer Edition, designed for generating standard supplemental reporting data. Other offerings include Subscribe, which allows for automatic updates for specific patient populations, and a scalable Hosted Solution. Diameter Health serves a diverse clientele, including government agencies, health information exchanges, payers, healthcare IT vendors, life insurers, and health systems. Founded in 2013, the company operates from its offices in Farmington, Connecticut, and Wellesley, Massachusetts.

Tru Optik

Venture Round in 2019
Tru Optik Data Corp. is a digital media intelligence company based in Stamford, Connecticut, specializing in audience measurement and data management for the streaming media ecosystem. Founded in 2013, the company offers a comprehensive OTT marketing cloud that enables brand marketers and media companies to measure audience engagement and consumer demand. Tru Optik provides a range of services, including OTT data management, analytics, consumer activation, and measurement solutions. Its patented Household Graph™, which encompasses over 80 million homes, facilitates identity resolution, allowing leading brands, agencies, and media companies to connect with consumers across various platforms, including OTT, streaming audio, and gaming. As of October 1, 2020, Tru Optik operates as a subsidiary of TransUnion, further enhancing its capabilities in the digital marketing landscape.

Allyx Therapeutics

Convertible Note in 2019
Allyx Therapeutics is a clinical-stage biotechnology company that develops therapies designed to reverse neurodegeneration. Allyx Therapeutics' product is an orally bioavailable small molecule that acts as a silent allosteric modulator, enabling clinicians to get a drug that is capable of delivering a disease-modifying approach and preserve cognition in patients.

Vizium

Convertible Note in 2019
Vizium provides Web-based eMarketing solutions designed to leverage the power and reach of the Internet. Through Their eMarketing ASP (Application Service Provider) model, Vizium offers on-going eMarketing consulting, technology implementation, and campaign management services for planning, designing, executing, and measuring electronic marketing campaigns.

Torigen Pharmaceuticals

Series A in 2019
Torigen Pharmaceuticals is a company focused on being at the forefront of immuno-oncology innovation. They strive to bring novel approaches to the market to tackle companion animal cancers, building on years of existing scientific research and pushing the boundaries of innovation.

Halda Therapeutics

Series A in 2019
Halda Therapeutics is a research-stage drug discovery company, seeking to create the next generation of precision medicine based on a novel therapeutic modality which may be a platform for a number of disease states.

Aureus Analytics

Series A in 2019
Aureus Analytics Pvt. Ltd. specializes in developing CRUX, an artificial intelligence-based analytics platform tailored for the insurance sector, specifically for property, casualty, and life insurance. Established in 2012 and headquartered in Singapore, with additional offices in Hartford, United States, and Mumbai, India, the company focuses on enhancing customer experience through predictive analytics and machine learning technologies. Aureus Analytics provides actionable insights to insurers, empowering them to make informed decisions that improve customer retention and loyalty. Its cloud-based solutions are designed to handle vast amounts of internal and external data, catering to insurers and banks of all sizes with a user-friendly interface and a subscription-based pricing model.

Phlatbed

Venture Round in 2019
Phlatbed Inc. is a consumer logistics company that operates an on-demand moving application, connecting customers with local drivers for various moving needs, including packing, loading, and junk removal. Founded in 2016 and based in Norwalk, Connecticut, the platform allows users to place real-time requests and choose from multiple drivers based on geographic location and service pricing. The application facilitates seamless transactions, with payments processed automatically through options like PayPal or credit card, while cash is also accepted. After the completion of a move, both customers and drivers can provide feedback to enhance service quality. Currently, Phlatbed operates across the United States and Canada, with plans to expand into the United Kingdom. The company also maintains an active blog and social media presence to engage with the community and provide updates on its services.

Bactana Corp.

Series A in 2019
Bactana Corporation is dedicated to researching and developing nutritional products aimed at improving microbiome health in livestock and other animals. The company focuses on its FPS-4 product platform, which enhances the interaction between an animal's immune system and metabolism to boost productivity while promoting overall health. This platform is derived from naturally occurring gut colonizers, particularly from the faecalibacterium prausnitzii species, initially identified for food-producing animals. Bactana's innovations leverage advanced molecular science and DNA sequencing techniques to create sustainable products that enhance the efficiency of raising dairy and beef cattle. Founded in 2016, Bactana Corporation is headquartered in Farmington, Connecticut, and primarily serves cattle farmers in Connecticut and New York.

CALT Dynamics

Seed Round in 2019
CALT stands for Computer Aided Life Technology. We’re creating a new generation of 3D printers, that operate using a new process we have invented and patented called Physical Mask Curing. This process, PMC for short, is enabling us to build printers that are higher resolution, have a lower investment cost and are completely scalable. This means we can build printers that are mobile and field ready with no computer or internet required, right up to industrial devices with much larger build volumes than ever seen before.

Upward

Grant in 2018
Upward is global incubator with a vision to re-invigorate second-tier cities through a generation of innovators with ideas that are fostered through connection, learning and experience. Our foundation city, Hartford CT, is already host to one of our flourishing integrated communities. A thriving ecosystem serving as the core to our principal Upward City. An Upward City is one that puts humans at the heart of innovation. It is a city driven by a community of tech-forward creators and innovators focused on improving quality of life. A city that works for you. Through vision and determination, Hartford CT, a city once in economic decline, is quickly proving positive transformation by adopting the Upward model. Upward is not limited to a building, neighborhood or demographic. Upward is the physical space, the community and the mindset. An ecosystem working in harmony to attract and retain a new generation of people who seek a place of enrichment. A desire for empowerment and success through collaboration, learning and lifestyle. We strive for a promising future for second-tier cities and motivated startups, ambitious change-makers, and dedicated entrepreneurs who aspire to a new way of working and living. Move Upward. Ideas start here.

WAVE Drowning Detection Systems

Pre Seed Round in 2018
WAVE was created with a mission to end drowning, a leading cause of death in children and adults. Our product works with lifeguards and parents to detect drowning at the first sign of danger.

1touch.io

Seed Round in 2018
By continuously analyzing traffic and repository stores connected to your network, our network-based solution can detect all elements on the network that are storing, processing, and sharing personal data, both internally and externally. Whether structured or unstructured data, data in motion or at rest, and even data that is unknown to you, 1touch.io can track it for you.

Source Defense

Series A in 2018
In an industry focused on detection, Source Defense provides websites with the first ever prevention technology for attacks of third-party origin. We are the first ever SAAS platform that allows a site owner to set and enforce permissions, receive real-time alerts and monitor third-party vendors' behavior on their site. By removing the security considerations from third-party integrations, we can save countless man-hours spent on tests and integrations, allowing sites to focus on generating revenues and new opportunities while keeping the site visitors safe and the site in high performance.

DiA Imaging Analysis

Series A in 2018
DiA Imaging Analysis Ltd. specializes in developing advanced decision support systems for the automatic diagnosis of cardiac function through echocardiographic examinations. The company offers a suite of AI-powered applications, including LVivo EF for ejection fraction analysis, LVivo RV for right ventricle assessment, and LVivo Strain for evaluating myocardial contraction and strain, which serve as early indicators of reduced left ventricular function. Additional tools include LVivo SWM for segmental wall motion evaluation, LVivo Seamless for optimal view selection, and LVivo SAX, which aids in detecting coronary heart disease. DiA also provides mobile ultrasound solutions with LVivo Mobile and converts traditional ultrasound to bladder scanning with LVivo Bladder. Founded in 2009 and based in Beersheba, Israel, DiA holds FDA and CE clearances for its cardiac tools, making its automated solutions accessible for integration into ultrasound devices and healthcare IT systems, addressing challenges in image acquisition and analysis faced by clinicians worldwide.

Inbox Health

Seed Round in 2018
Inbox Health's mission is to greatly reduce the administrative waste in healthcare, by streamlining the patient billing and payment experience. Their product is a patient billing and communication platform that uses patient data to tailor a billing process specific to the patient’s situation and behavior patterns.
In the Farmington, Connecticut area, Tunxis Community College has academic, workforce training, and personal enrichment courses for students with all sorts of different interests that can earn you an associate’s degree or certificate. Among the many majors to choose from are programs such as Allied Health, Graphic Design, Visual Fine Arts, Business Office Technology, Computer Information Systems, Criminal Justice, Drug and Alcohol Recovery Counselor, Early Childhood Education, Engineering Science and Technology Studies, and New Media Communication, as well as many more. Counselors in the financial aid office can point you toward programs that will help you earn loans, grants, scholarships, veteran’s benefits, and more if you qualify. These financial aid options can help you pay for tuition and other expenses. Student life at TCC includes a student lounge, The Cyber Café, and the Barnes-Franklin Gallery, which is filled with student, community, and professional art. Academic advising is available for any student who needs help. The career center can help students find employment. Other student resources includes child care, health care, media center, and student activities.

Phlatbed

Venture Round in 2018
Phlatbed Inc. is a consumer logistics company that operates an on-demand moving application, connecting customers with local drivers for various moving needs, including packing, loading, and junk removal. Founded in 2016 and based in Norwalk, Connecticut, the platform allows users to place real-time requests and choose from multiple drivers based on geographic location and service pricing. The application facilitates seamless transactions, with payments processed automatically through options like PayPal or credit card, while cash is also accepted. After the completion of a move, both customers and drivers can provide feedback to enhance service quality. Currently, Phlatbed operates across the United States and Canada, with plans to expand into the United Kingdom. The company also maintains an active blog and social media presence to engage with the community and provide updates on its services.

Vacayo

Seed Round in 2018
Vacayo is a real estate management and service platform that helps owners rent their properties seamlessly and with higher income, leveraging Superhosts for on-the-ground operations. Despite the growth of the sharing economy, homeowners monetize less than 2 million of the 8 million second homes in the US. We leverage technology & big data to higher profits, total coverage, and better options owners. Vacayo allows owners to put their vacation rental on autopilot. Our system is cutting the typical costs of property management companies by 30%-60%.

ReNetX Bio

Series A in 2018
ReNetX Bio, Inc., a biotechnology company, develops and markets therapeutics to treat injury/damage to the central nervous system. It offers Nogo Trap, a decoy receptor that binds the growth inhibitors allowing the body to grow nerve fibers naturally and directly targeting restoration across all facets of growth, such as axonal regeneration, axonal sprouting, and synaptic plasticity. The company offers treatment for central nervous system for conditions, such as spinal cord injury, stroke, and glaucoma. ReNetX Bio, Inc. was formerly known as Axerion Therapeutics, Inc. and changed its name to ReNetX Bio, Inc. in July 2017. The company was incorporated in 2009 and is based in New Haven, Connecticut.

OncoSynergy

Series A in 2018
The vision of OncoSynergy, a UCSF spin-out, is to radically improve outcomes for patients with unmet needs in oncology with Resistance Mechanism Inhibitors (RMIs). This new class of therapeutics simultaneously targets multiple hallmarks of cancer progression and have demonstrated dramatic preclinical efficacy as monotherapy and in strategic combinations. It was founded in 2011 and is headquartered in Greenwich, Connecticut.